Showing results (161-170 of 377) with videos related to
Sort By:
Pageof 38
Heliyon|October 14, 2024
Cabozantinib prevents the progression of metabolic dysfunction-associated steatohepatitis by inhibiting the activation of hepatic stellate cell and macrophage and attenuating angiogenic activityTakuya Matsuda, Kosuke Kaji, Norihisa Nishimura, et al.Journal of Angiogenesis Research|August 25, 2010
The vascular endothelial growth factor (VEGF) receptor-2 is a major regulator of VEGF-mediated salvage effect in murine acute hepatic failureTadashi Namisaki, Hitoshi Yoshiji, Ryuichi Noguchi, et al.ACS Biomaterials Science & Engineering|May 9, 2023
Drug Delivery with Hyaluronic Acid-Coated Polymeric Micelles in Liver Fibrosis TherapyYuta Yoshizaki, Manami Yamasaki, Takuya Nagata, et al.Alcoholism, Clinical and Experimental Research|March 3, 2007
Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitisTomomi Matsuyama, Masahito Uemura, Masatoshi Ishikawa, et al.Oncology Reports|April 6, 2005
Safe and efficient transgene expression in rat hepatocytes induced by adenoviral administration into the biliary tractShigeki Kuriyama, Hitoshi Yoshiji, Akihiro Deguchi, et al.Cancer Letters|July 23, 2018
Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated proteinSoichiro Saikawa, Kosuke Kaji, Norihisa Nishimura, et al.Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 5, 2023
Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic miceSatoshi Iwai, Kosuke Kaji, Norihisa Nishimura, et al.Microorganisms|June 25, 2020
Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic SteatohepatitisYuki Tsuji, Kosuke Kaji, Mitsuteru Kitade, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 6, 2022
Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet-induced rat steatohepatitisMasahide Enomoto, Kosuke Kaji, Norihisa Nishimura, et al.Cells|September 29, 2019
TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic RatsDaisuke Kaya, Kosuke Kaji, Yuki Tsuji, et al.Pageof 38